Top in cardiology: Type 2 diabetes risk score, decline in Kawasaki disease
Researchers developed a genetic risk score that depicts the relationship between variants in HMGCR and pleiotropic effects of statins. They found that a certain HMGCR risk score was associated with an increased odds of type 2 diabetes.
A report on the data was the top story in cardiology last week.
Another top story revealed that social distancing and COVID-19 prevention efforts have contributed to a decrease in Kawasaki disease in South Korea. A retrospective, ecologic study found the incident rate of Kawasaki disease prior to the pandemic was about 4.1 per 100,000 persons. During the pandemic, it decreased to less than 2 per 100,000 persons.
Read these and more top stories in cardiology below:
In genetic analysis, statin-induced LDL decline linked to new-onset diabetes
In a Mendelian randomization analysis, LDL reduction associated with statin use was linked to elevated odds of type 2 diabetes, but not with other pleiotropic effects. Read more.
Decline in Kawasaki disease may be linked to pandemic preventive measures
The decrease in Kawasaki disease rates in South Korea during the COVID-19 pandemic may be attributable to pandemic prevention efforts, including mask-wearing, hand-washing and physical distancing, researchers reported. Read more.
TEE can detect left atrial thrombus in patients with AF undergoing procedures
The prevalence of left atrial thrombus is high in certain anticoagulated patients with atrial fibrillation, which suggests a role for transesophageal echocardiogram imaging before procedures in that population, researchers reported. Read more.
Q&A: New analysis upholds dental antibiotic prophylaxis guidelines in patients with CVD
The 2007 decision to no longer advise antibiotic prophylaxis to prevent viridans group streptococcal infective endocarditis in many patients with CVD having invasive dental procedures was correct, according to a new scientific statement. Read more.
Many adults with CVD continue to smoke despite risks
More than one-fourth of adults with CVD use tobacco products and few of them quit over 5 years, researchers reported. Read more.